Photoelectron Corporation has signed an exclusive agreement with Cordis Corporation, a Johnson & Johnson Company, to co-develop and co- manufacture a disposable miniature x-ray source and associated technology for the delivery of intravascular radiation therapy to prevent restenosis of coronary arteries following angioplasty and stent procedures.
Cordis Corporation is a leader in circulatory disease management.
Additionally, Photoelectron announced that Johnson & Johnson Development Corporation has made a $3.8 million equity investment in Photoelectron’s common stock which is not required to be registered for a period of twelve months.
“We are pleased to have signed these agreements with Cordis Corporation and Johnson & Johnson Development Corporation,” stated Euan Thomson, Ph.D., President and CEO, Photoelectron Corporation.
“This $3.8 million investment is expected to provide us with the necessary resources to quickly complete development and successfully launch this new x-ray delivery system to treat cardiac patients requiring angioplasty and stent procedures.”
Under the terms of the agreement with Cordis, the companies will develop and manufacture an x-ray system based on Photoelectron’s patented technology.
The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy.
Both companies will manufacture components for the system, which will be co- labeled.
Cordis will be responsible for the sales and marketing for the new x-ray system.
Photoelectron Corporation is a medical device and technology company specializing in miniature x-ray technology for the medical and industrial markets.
The company has secured both regulatory approval and broad distribution channels for their current products.
Shop Dragon Pharma Steroids
Legal Dragon Pharma Anabolic Steroids – pharmaceutical company that manufactures steroid gear: Dianabol for Sale.